| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918306 | Radiotherapy and Oncology | 2014 | 8 Pages |
Abstract
The high number of near-pCR with ypT3 or ypN1/2 and their poor outcome demonstrates that “watch-and-wait” in LARC patients should be applied with care.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hendrik A.M. Swellengrebel, Steven L. Bosch, Annemieke Cats, Andrew D. Vincent, Luc G.H. Dewit, Vic J. Verwaal, Iris D. Nagtegaal, Corrie A.M. Marijnen,